Literature DB >> 24940462

Bladder tumour antigen (BTA stat) test compared to the urine cytology in the diagnosis of bladder cancer: A meta-analysis.

Aiye Guo1, Xiuhua Wang2, Lan Gao1, Juan Shi1, Changyi Sun1, Zhen Wan1.   

Abstract

INTRODUCTION: We evaluate the diagnostic value of bladder tumour antigen (BTA stat) tests compared with urine cytology test in detecting bladder cancer.
METHODS: We searched public databases including PubMed, MEDLINE Springer, Elsevier Science Direct, Cochrane Library and Google Scholar before December 2012. To collect relevant data of BTA stat tests and urine cytology tests in patients with bladder cancer, we studied meta-analyses of sensitivity, specificity, positive likelihood ratio (LR), negative LR and diagnostic odds ratios (DOR) of BTA stat tests and cytology tests from published studies. We applied the software of Rev. Man 5.1 and Stata 11.0 to the meta-analysis.
RESULTS: A total of 13 separate studies consisting of 3462 patients with bladder cancer were considered in the meta-analysis. We found that the BTA stat test had a higher sensitivity than the urine cytology test (0.67, 95% confidence interval [CI] 0.64 to 0.69 vs. 0.43, 95% CI 0.40 to 0.46), but the specificity, positive LR, negative LR, DOR, the area under the curve (AUC) and Q index of the BTA stat test were lower compared with the urine cytology test. The results of the Egger's linear regression test showed no publication bias (p > 0.05).
CONCLUSIONS: Specificity, positive LR, negative LR, DOR, the AUC and the Q index of the urine cytology test may be superior to the BTA stat test, but the BTA stat test has greater sensitivity than the urine cytology test.

Entities:  

Year:  2014        PMID: 24940462      PMCID: PMC4039599          DOI: 10.5489/cuaj.1668

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  31 in total

1.  [Screening methods in the detection of bladder cancer: comparison of nuclear matrix protein-22, bladder tumor antigen and cytological examinations].

Authors:  Y Fukui; S Samma; K Fujimoto; T Akiyama; A Yamaguchi; A Hirayama
Journal:  Hinyokika Kiyo       Date:  2001-05

2.  Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer.

Authors:  H Leyh; M Marberger; P Conort; C Sternberg; V Pansadoro; F Pagano; P Bassi; L Boccon-Gibod; V Ravery; U Treiber; L Ishak
Journal:  Eur Urol       Date:  1999-01       Impact factor: 20.096

3.  Improved detection of recurrent bladder cancer using the Bard BTA stat Test.

Authors:  M F Sarosdy; M A Hudson; W J Ellis; M S Soloway; R deVere White; J Sheinfeld; M V Jarowenko; P F Schellhammer; E W Schervish; J V Patel; G W Chodak; D L Lamm; R D Johnson; M Henderson; G Adams; B A Blumenstein; K R Thoelke; R D Pfalzgraf; H A Murchison; S L Brunelle
Journal:  Urology       Date:  1997-09       Impact factor: 2.649

4.  Microsatellite analysis--DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial.

Authors:  B W van Rhijn; I Lurkin; W J Kirkels; T H van der Kwast; E C Zwarthoff
Journal:  Cancer       Date:  2001-08-15       Impact factor: 6.860

5.  Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: a utility analysis.

Authors:  J L Vriesema; M H Poucki; L A Kiemeney; J A Witjes
Journal:  Urology       Date:  2000-11-01       Impact factor: 2.649

6.  A study comparing various noninvasive methods of detecting bladder cancer in urine.

Authors:  A Saad; D C Hanbury; T A McNicholas; G B Boustead; S Morgan; A C Woodman
Journal:  BJU Int       Date:  2002-03       Impact factor: 5.588

7.  A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results.

Authors:  V Poulakis; U Witzsch; R De Vries; H M Altmannsberger; M J Manyak; E Becht
Journal:  BJU Int       Date:  2001-11       Impact factor: 5.588

8.  Upregulation of tissue and urinary nicotinamide N-methyltransferase in bladder cancer: potential for the development of a urine-based diagnostic test.

Authors:  Davide Sartini; Giovanni Muzzonigro; Giulio Milanese; Valentina Pozzi; Alexia Vici; Stefano Morganti; Valentina Rossi; Roberta Mazzucchelli; Rodolfo Montironi; Monica Emanuelli
Journal:  Cell Biochem Biophys       Date:  2013-04       Impact factor: 2.194

9.  Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms.

Authors:  W M Murphy; M S Soloway; A F Jukkola; W N Crabtree; K S Ford
Journal:  Cancer       Date:  1984-04-01       Impact factor: 6.860

10.  [Usefulness of BTA Stat test (Bard) in the diagnosis of bladder cancer. Preliminary results and comparison with cytology and cystoscopy].

Authors:  J L Gutiérrez Baños; B Martín García; R Hernández Rodríguez; J A Portillo Martín; M A Correas Gómez; J I del Valle Schaan; A Roca Edreira; A Villanueva Peña; R Gutíerrez García; E De Diego Rodríguez; M A Rado Velázquez
Journal:  Arch Esp Urol       Date:  1998-10       Impact factor: 0.436

View more
  20 in total

Review 1.  [Urinary marker-old wine in new bottles?]

Authors:  K Fischer
Journal:  Urologe A       Date:  2018-09       Impact factor: 0.639

2.  Interaction network analysis of differentially expressed genes and screening of cancer marker in the urine of patients with invasive bladder cancer.

Authors:  Baihong Guo; Tuanjie Che; Baoguang Shi; Lijun Guo; Zhihua Zhang; Lin Li; Chuanyong Cai; Yirong Chen
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 3.  Developing proteomic biomarkers for bladder cancer: towards clinical application.

Authors:  Maria Frantzi; Agnieszka Latosinska; Leif Flühe; Marie C Hupe; Elena Critselis; Mario W Kramer; Axel S Merseburger; Harald Mischak; Antonia Vlahou
Journal:  Nat Rev Urol       Date:  2015-05-26       Impact factor: 14.432

4.  SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling.

Authors:  Zhongqiu Zhou; Zhuojun Zhang; Han Chen; Wenhao Bao; Xiangqin Kuang; Ping Zhou; Zhiqing Gao; Difeng Li; Xiaoyi Xie; Chunxiao Yang; Xuhong Chen; Jinyuan Pan; Ruiming Tang; Zhengfu Feng; Lihuan Zhou; Lan Wang; Jianan Yang; Lili Jiang
Journal:  Br J Cancer       Date:  2022-04-28       Impact factor: 9.075

5.  Combination of Urine Exosomal mRNAs and lncRNAs as Novel Diagnostic Biomarkers for Bladder Cancer.

Authors:  Haiming Huang; Jialin Du; Bo Jin; Lu Pang; Nan Duan; Chenwei Huang; Jiayin Hou; Wei Yu; Han Hao; Haixia Li
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

Review 6.  Novel non invasive diagnostic strategies in bladder cancer.

Authors:  Anamaria Truta; Tudor Adrian Hodor Popon; George Saraci; Liviu Ghervan; Ioan Victor Pop
Journal:  Clujul Med       Date:  2016-04-15

7.  Clinical Significance of Serological and Urological Levels of Bladder Cancer-Specific Antigen-1 (BLCA-1) in Bladder Cancer.

Authors:  Zhiyong Wang; Hongyang Li; Qiang Chi; Yu Qiu; Xiuming Li; Lisheng Xin
Journal:  Med Sci Monit       Date:  2018-06-08

8.  Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B.

Authors:  Yang Yang; Jianjun Xu; Qingyun Zhang
Journal:  Oncol Lett       Date:  2018-03-22       Impact factor: 2.967

Review 9.  Recent advances in mass spectrometry based clinical proteomics: applications to cancer research.

Authors:  Andrew Macklin; Shahbaz Khan; Thomas Kislinger
Journal:  Clin Proteomics       Date:  2020-05-24       Impact factor: 3.988

Review 10.  Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring.

Authors:  Iris Lodewijk; Marta Dueñas; Carolina Rubio; Ester Munera-Maravilla; Cristina Segovia; Alejandra Bernardini; Alicia Teijeira; Jesús M Paramio; Cristian Suárez-Cabrera
Journal:  Int J Mol Sci       Date:  2018-08-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.